<?xml version="1.0" encoding="UTF-8"?>
<p>Middle East respiratory syndrome, caused by MERS-CoV (in 2012), is also known to be potentially neuroinvasive with features ranging from altered mentation, confusion, ataxia and ophthalmoplegia to focal neurological deficits and coma.
 <sup>
  <xref rid="r52" ref-type="bibr">52</xref>
 </sup> Radiological findings have been shown to range from intracerebral hemorrhages, ischemic strokes to encephalitic features.
 <sup>
  <xref rid="r52" ref-type="bibr">52</xref>
 </sup> Involvement of the peripheral nervous system in the form of Guillain–Barré syndrome (GBS) and critical illness polyneuropathy have also been reported.
 <sup>
  <xref rid="r52" ref-type="bibr">52</xref>
 </sup> In a retrospective study by Saad et al.
 <sup>
  <xref rid="r53" ref-type="bibr">53</xref>
 </sup> in 2014, CNS manifestations in the form of confusion, headache and seizures were noted in 25.7%, 12.9% and 8.6% of patients, respectively. Rhabdomyolysis was seen in 14.3% of MERS-CoV patients.
 <sup>
  <xref rid="r53" ref-type="bibr">53</xref>
 </sup>
</p>
